FIWBX
Price
$15.77
Change
-$0.07 (-0.44%)
Updated
Jul 31 closing price
Net Assets
3.53B
RLBCX
Price
$40.12
Change
+$0.08 (+0.20%)
Updated
Jul 31 closing price
Net Assets
288.09B
Interact to see
Advertisement

FIWBX vs RLBCX

FIWBX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
FIWBX vs. RLBCX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIWBX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 288B vs. FIWBX (3.53B). FIWBX pays higher dividends than RLBCX: FIWBX (3.79) vs RLBCX (1.53). FIWBX was incepted earlier than RLBCX: FIWBX (8 years) vs RLBCX (24 years). RLBCX (0.89) is less costly to investors than FIWBX (0.77). FIWBX is a more actively managed with annual turnover of: 225.00 vs. RLBCX (50.00). FIWBX has a lower initial minimum investment than RLBCX: FIWBX (0) vs RLBCX (250). RLBCX annual gain was more profitable for investors over the last year : 10.94 vs. FIWBX (9.83). FIWBX (31.29) and RLBCX (30.59) have equivalent 5 years return.
FIWBXRLBCXFIWBX / RLBCX
Total Expense Ratio0.760.8985%
Annual Report Gross Expense Ratio0.770.8987%
Fund Existence8 years24 years-
Gain YTD3.9338.22048%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.53B288B1%
Annual Yield % from dividends3.791.53247%
Returns for 1 year9.8310.9490%
Returns for 3 years34.6337.3093%
Returns for 5 years31.2930.59102%
Returns for 10 yearsN/A78.60-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WSE12.00-0.06
-0.50%
Wise Group Plc
BCRX8.98-0.26
-2.81%
BioCryst Pharmaceuticals
RNTX0.74-0.03
-3.98%
Rein Therapeutics Inc
PACB1.40-0.08
-5.41%
Pacific Biosciences of California
BTSGU199.48-38.89
-16.31%
BrightSpring Health Services